HIGHLIGHTS OF PRESCRIBING INFORMATION: OZEMPIC (semaglutide) injection, for subcutaneous use
He personalizes the medication, dosage, and treatment strategy based on your health history, lab results, goals, tolerance, and response over time
[3] Other common adverse effects reported during the clinical trials include back pain, upper respiratory tract infections, melanocyte naevus, decreased appetite, migraine, dizziness, weakness, fatigue, lethargy, sleepiness, hot flashes, abdominal pain, diarrhea, vomiting, flushing, development of warts, spots, and freckles, and itchy skin (between 1% and 10% of people)
Insoluble fiber isnt digested by your body, and creates bulk to move stool along and out of your digestive tract
The peptide represents a modified version of the 176-191 amino acid sequence from growth hormones C-terminal region, with a tyrosine addition at the N-terminus for stability